Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 13 studies | 34% ± 18% | |
basal cell | 10 studies | 32% ± 15% | |
secretory cell | 9 studies | 24% ± 10% | |
endothelial cell | 9 studies | 30% ± 11% | |
goblet cell | 7 studies | 25% ± 9% | |
type I pneumocyte | 6 studies | 31% ± 13% | |
enterocyte | 6 studies | 20% ± 4% | |
club cell | 5 studies | 32% ± 17% | |
respiratory goblet cell | 5 studies | 27% ± 18% | |
ciliated cell | 5 studies | 34% ± 9% | |
abnormal cell | 5 studies | 21% ± 3% | |
progenitor cell | 4 studies | 19% ± 3% | |
capillary endothelial cell | 4 studies | 26% ± 7% | |
brush cell | 4 studies | 22% ± 7% | |
ionocyte | 3 studies | 18% ± 3% | |
transit amplifying cell | 3 studies | 19% ± 1% | |
type II pneumocyte | 3 studies | 34% ± 11% | |
retinal pigment epithelial cell | 3 studies | 46% ± 12% | |
endothelial cell of artery | 3 studies | 21% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 5478.00 | 328 / 328 | 99% | 377.93 | 177 / 178 |
lung | 99% | 2796.61 | 572 / 578 | 98% | 290.49 | 1131 / 1155 |
breast | 98% | 2565.45 | 452 / 459 | 97% | 191.79 | 1090 / 1118 |
prostate | 97% | 2649.43 | 237 / 245 | 99% | 183.43 | 497 / 502 |
thymus | 100% | 3517.51 | 653 / 653 | 93% | 181.12 | 565 / 605 |
liver | 100% | 7057.10 | 226 / 226 | 91% | 214.87 | 368 / 406 |
uterus | 95% | 1395.83 | 162 / 170 | 91% | 287.87 | 418 / 459 |
stomach | 87% | 5244.09 | 313 / 359 | 98% | 387.00 | 280 / 286 |
kidney | 100% | 2512.37 | 89 / 89 | 84% | 79.80 | 757 / 901 |
bladder | 81% | 1600.86 | 17 / 21 | 96% | 356.95 | 482 / 504 |
esophagus | 68% | 1956.19 | 976 / 1445 | 98% | 299.50 | 180 / 183 |
intestine | 67% | 4231.65 | 643 / 966 | 98% | 397.98 | 519 / 527 |
ovary | 66% | 512.61 | 118 / 180 | 99% | 359.99 | 427 / 430 |
adrenal gland | 100% | 2820.91 | 258 / 258 | 22% | 29.47 | 51 / 230 |
tonsil | 0% | 0 | 0 / 0 | 100% | 248.18 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 160.97 | 1 / 1 |
spleen | 100% | 1734.38 | 240 / 241 | 0% | 0 | 0 / 0 |
adipose | 95% | 1365.06 | 1141 / 1204 | 0% | 0 | 0 / 0 |
skin | 72% | 3033.73 | 1308 / 1809 | 17% | 18.15 | 80 / 472 |
blood vessel | 54% | 465.74 | 723 / 1335 | 0% | 0 | 0 / 0 |
brain | 48% | 394.10 | 1264 / 2642 | 2% | 1.53 | 14 / 705 |
peripheral blood | 36% | 596.23 | 337 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 24% | 17.91 | 7 / 29 |
heart | 20% | 128.75 | 168 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 8% | 4.78 | 6 / 80 |
muscle | 5% | 31.35 | 41 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035633 | Biological process | maintenance of blood-brain barrier |
GO_0061833 | Biological process | protein localization to tricellular tight junction |
GO_0060856 | Biological process | establishment of blood-brain barrier |
GO_0001889 | Biological process | liver development |
GO_0010669 | Biological process | epithelial structure maintenance |
GO_1904274 | Biological process | tricellular tight junction assembly |
GO_0061436 | Biological process | establishment of skin barrier |
GO_0042627 | Cellular component | chylomicron |
GO_0030054 | Cellular component | cell junction |
GO_0034362 | Cellular component | low-density lipoprotein particle |
GO_0070160 | Cellular component | tight junction |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0061689 | Cellular component | tricellular tight junction |
GO_0034361 | Cellular component | very-low-density lipoprotein particle |
GO_0005923 | Cellular component | bicellular tight junction |
Gene name | LSR |
Protein name | LSR protein Lipolysis stimulated lipoprotein receptor Lipolysis-stimulated lipoprotein receptor (Angulin-1) |
Synonyms | LISCH ILDR3 |
Description | FUNCTION: Probable role in the clearance of triglyceride-rich lipoprotein from blood. Binds chylomicrons, LDL and VLDL in presence of free fatty acids and allows their subsequent uptake in the cells (By similarity). Maintains epithelial barrier function by recruiting MARVELD2/tricellulin to tricellular tight junctions (By similarity). . |
Accessions | Q86X29 ENST00000599658.1 Q9BWS2 ENST00000605618.6 ENST00000360798.7 ENST00000361790.7 ENST00000347609.8 [Q86X29-2] ENST00000601623.5 M0R0W1 S4R3V8 ENST00000427250.5 [Q86X29-6] A0A8Z5DL71 M0QZL9 A0A8Z5ABK9 ENST00000621372.4 [Q86X29-1] A0A8Z5AA41 M0R1W9 ENST00000602003.1 ENST00000354900.7 ENST00000602122.5 |